Clinical Trial

A Study to Assess the Safety and Efficacy of AGN-151586 Injections for the Treatment of Moderate to Severe Forehead Lines (FHL) in Adult Participants

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate the safety and efficacy of AGN-151586 for the treatment of moderate to severe forehead lines (FHL) in adult participants.
Trial Details
NCT Number NCT07730554
Lead Sponsor AbbVie
Conditions Forehead Lines
Enrollment 80 participants
Start Date 2026-07-28
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-28